{"SPADE_N_07171": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07171", "Peptide Name": "TCTP-CPP 32", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "LIIFRILISHR", "Sequence Length": 11, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "FITC", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C66H113N19O13", "Mass": 1380.72, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": 1.4, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.", "Pubmed ID": "21440624", "Reference": "Eur J Pharm Sci. 2011 May 18;43(1-2)25-78.", "Author": "Kim M, Maeng J, Jung J, Kim HY, Kim HJ, Kwon Y, Lee K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21440624"}], "Frequent Amino Acids": "ILR", "Absent Amino Acids": "ACDEGKMNOPQTUVWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 4, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07168", "Similarity": 1.0, "Sequence": "LIIFRILISHRR"}, {"SPADE_ID": "SPADE_N_07172", "Similarity": 1.0, "Sequence": "LIIFRILISH"}, {"SPADE_ID": "SPADE_UN_07488", "Similarity": 1.0, "Sequence": "LIDCKTVDDCPSSWTKIYKCIDNKCRYSVVKGLII"}]}}}